Volumetric Pouch Study After Laparoscopic Sleeve Gastrectomy
1 other identifier
interventional
40
1 country
1
Brief Summary
This study aimed to evaluate Laparoscopic Sleeve Gastrectomy in the treatment of morbidly obese patients pre and post-operatively after 3 months, 6 months, and 1-year follow-up and assess the volumetric changes of the gastric reservoir 1 year after LSG using multi-slice computer tomography.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2020
CompletedFirst Submitted
Initial submission to the registry
May 6, 2021
CompletedFirst Posted
Study publicly available on registry
May 11, 2021
CompletedMay 11, 2021
May 1, 2021
1.9 years
May 6, 2021
May 10, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Gastric volume after surgery
gastric reservoir volume after performance of laparoscopic sleeve gastrectomy
1 month
Study Arms (1)
sleeve gastrectomy followed by volumetric assessment
EXPERIMENTALInterventions
Laparoscopic sleeve gastrectomy had evident therapeutic effects on preexisting obesity-related comorbidities. All patients were referred for abdominal MSCT with a volumetric assessment of gastric pouch within 1 month of surgery and 1 year postoperatively
Eligibility Criteria
You may qualify if:
- BMI of \> 40 kg/m 2 or \> 35 kg/m2 with comorbidities e.g. hypertension and type 2 DM.
- All patients failed in supervised conservative management for obesity for at least 2 years.
You may not qualify if:
- BMI \> 60
- previous bariatric surgery
- symptomatic reflux oesophagitis disease, gastric pathology (tumor, active peptic ulcer)
- Significant psychological disorder, active alcohol or substance abuse
- severe eating disorders (bulimia)
- severe systemic disease making anesthesia or surgery prohibitively risky (American Society of Anesthesiologists (ASA) class IV
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kafrelsheikh university
Kafr ash Shaykh, 33516, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr, assistant lecturer of General Surgery
Study Record Dates
First Submitted
May 6, 2021
First Posted
May 11, 2021
Study Start
November 1, 2018
Primary Completion
October 1, 2020
Study Completion
November 1, 2020
Last Updated
May 11, 2021
Record last verified: 2021-05
Data Sharing
- IPD Sharing
- Will not share